Results for developed bharat biotech

Add to feed Create your own feed

Latest

Along with Covaxin, which is being developed by Bharat Biotech, and ZyCov-D (Zydus Cadila), there are 11 vaccine candidates out of a total of 140 which have entered the human trials stage.

Bharat Biotech International has successfully developed India’s first indigenous vaccine candidate for COVID-19 to enter human trials. Named Covaxin, the vaccine has been cleared by the DCGI and Ministry of Health & Family Welfare for phase I and II trials

ICMR’s process is exactly in accordance with globally accepted norms to fast-track the vaccine development for diseases of pandemic potential wherein human and animal trials can continue in parallel: ICMR on #COVID19  vaccine candidate developed by Bharat Biotech International Ltd

India’s top health research body on Saturday said that fast tracking of clinical trials of the indigenous Covid-19 vaccine being developed by Bharat Biotech International Ltd is in accordance with the globally accepted norms.

India's premier medical body ICMR has said 12 clinical trial sites for the indigenous Covaxin, being developed in collaboration with the Hyderabad-based Bharat Biotech and the National Institute of Virology (NIV), have been identified.

#ExpressFrontPage | The potential vaccine is being developed by Bharat Biotech, a Hyderabad-based pharmaceutical company, in partnership with Pune-based National Institute of Virology, an ICMR laboratory

Inactivated #COVID19  vaccine candidate has been developed by Bharat Biotech in collaboration with @ICMRDELHI . #ICMR  supporting clinical development as vaccine candidate appears promising; based on in-depth scrutiny, DCGI accords permission to conduct phase 1, 2 clinical trial

tweet picture

All other Covid-19 vaccine candidates across the globe have been similarly fast-tracked, says ICMR about 15 August deadline for the vaccine being developed by Bharat Biotech

The Indian Council of Medical Research has written to Bharat Biotech India Ltd to expedite the clinical trials for their jointly developed covid-19 vaccine 'Covaxin' ready for launch by Independence Day on 15 August.

Vaccine candidate #Covaxin , jointly developed by Bharat Biotech, #ICMR  & NIV just been cleared to conduct Phase-I & II human trials by Drug Controller General of India ICMR’s Aug 15 target for #COVID19  #vaccine  launch unrealistic, say experts

Loading
Loading

Most relevant

India’s first #COVID19  vaccine candidate COVAXIN has received approval of DCGI for phase I & II of human clinical trials. The drug has been developed by Bharat Biotech. Human clinical trials are scheduled to start across India in July 2020

Drug Controller General of India gives approval for human clinical trials of #COVAXIN , the 1st potential #Covid_19  Vaccine developed in India. ▪️ The potential vaccine has been developed by Hyderabad-based Bharat Biotech, in association with Indian Council of Medical Research.

tweet picture

India Aiming To Launch Covid-19 Vaccine Developed By Bharat Biotech By August 15 - RTRS

India’s first COVID-19 vaccine candidate COVAXIN gets DCGI approval. Developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology #COVID  #COVID191  @CNBCTV18Live9 

Drug Controller General of India gives approval to Hyderabad based Bharat Biotech for phase I & II human clinical trials of ‘Covaxin’ to develop indigenous vaccine for #COVID19 . Bharat Biotech Chairman Dr Krishna Ella says, "It was developed in partnership with ICMR & NIV Pune."

tweet picture

Bharat Biotech Limited developed 2 promising #ZikaVirus  vaccines; says need Govt's help to take vaccines forward

tweet picture

Loading
Loading